| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
| |
|
|
relating to the Texas Pharmaceutical Initiative. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Section 2177.003(a), Government Code, is amended |
|
|
to read as follows: |
|
|
(a) The initiative is governed by a board composed of five |
|
|
[three] members appointed by the governor. |
|
|
SECTION 2. Chapter 2177, Government Code, is amended by |
|
|
adding Section 2177.0035 to read as follows: |
|
|
Sec. 2177.0035. TERMS; VACANCIES. (a) Board members serve |
|
|
staggered six-year terms, with one-third or as near as possible to |
|
|
one-third of the members' terms expiring February 1 of each |
|
|
odd-numbered year. |
|
|
(b) A vacancy on the board shall be filled for the unexpired |
|
|
term in the same manner as the original appointment. |
|
|
SECTION 3. Section 2177.006, Government Code, is amended to |
|
|
read as follows: |
|
|
Sec. 2177.006. BUSINESS PLAN. Not later than June 1 of each |
|
|
even-numbered year [October 1, 2024], the board shall prepare |
|
|
[develop] and submit to the governor, the legislature, and the |
|
|
Legislative Budget Board a business plan on: |
|
|
(1) implementing the initiative, including the |
|
|
initiative's organizational structure and related programs; |
|
|
(2) establishing procedures and policies for the |
|
|
administration of the initiative, including documenting the |
|
|
process and resources required for the provision to individuals |
|
|
described by Section 2177.002 of the following services: |
|
|
(A) establishing or contracting for statewide |
|
|
pharmacy benefit manager services; |
|
|
(B) establishing policies and conditions to |
|
|
operate or contract for the operation of a distribution network, |
|
|
central service center, and associated network of satellite |
|
|
distribution facilities to distribute prescription drugs and |
|
|
related medical supplies; and |
|
|
(C) providing advanced pharmaceutical |
|
|
preparation and related services, including: |
|
|
(i) manufacturing generic drugs and generic |
|
|
biological products; |
|
|
(ii) providing gene therapies and precision |
|
|
medicine; and |
|
|
(iii) providing advanced laboratories for |
|
|
quality control, preparation, and compounding of drugs in support |
|
|
of innovative therapeutics and drug research; |
|
|
(3) establishing procedures to document compliance by |
|
|
board members and personnel with applicable laws governing |
|
|
conflicts of interest; |
|
|
(4) establishing the conditions for state agencies |
|
|
that facilitate health plans to participate in the initiative; |
|
|
(5) identifying potential cost savings from |
|
|
implementation of the initiative; |
|
|
(6) identifying the funding and resources needed to |
|
|
implement this chapter; |
|
|
(7) providing recommendations on best practices and |
|
|
cost savings related to the provision of pharmacy benefits using |
|
|
program utilization; and |
|
|
(8) [(7)] providing other board recommendations, with |
|
|
supporting documentation, on continuation of the initiative. |
|
|
SECTION 4. Section 2177.010, Government Code, is amended to |
|
|
read as follows: |
|
|
Sec. 2177.010. EXPIRATION OF CHAPTER. This chapter expires |
|
|
September 1, 2031 [2025]. |
|
|
SECTION 5. (a) As soon as practicable after the effective |
|
|
date of this Act, the governor shall appoint the governing board |
|
|
members for the Texas Pharmaceutical Initiative as required by |
|
|
Section 2177.003, Government Code, as amended by this Act. |
|
|
(b) Notwithstanding Section 2177.0035, Government Code, as |
|
|
added by this Act, in making the appointments of the governing board |
|
|
members for the Texas Pharmaceutical Initiative under Subsection |
|
|
(a) of this section, the governor shall designate: |
|
|
(1) two members to serve terms expiring February 1, |
|
|
2027; |
|
|
(2) two members to serve terms expiring February 1, |
|
|
2029; and |
|
|
(3) one member to serve a term expiring February 1, |
|
|
2031. |
|
|
SECTION 6. This Act takes effect September 1, 2025. |
|
|
|
|
|
* * * * * |